![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 13
2023
Stevens, Wendy B. C.; Los-de Vries, G. Tjitske; Langois-Jacques, Carole; Clear, Andrew J.; Stathi, Phylicia; Sander, Birgitta; Rosenwald, Andreas; Calaminici, Maria; Hoster, Eva 
ORCID: https://orcid.org/0000-0002-0749-1389; Hiddemann, Wolfgang; Gaulard, Philippe; Salles, Gilles; Klapper, Wolfram; Xerri, Luc; Burton, Catherine; Tooze, Reuben M.; Smith, Alexandra G.; Buske, Christian; Scott, David W.; Natkunam, Yasodha; Advani, Ranjana; Sehn, Laurie H.; Raemaekers, John; Gribben, John; Lockmer, Sandra; Kimby, Eva; Kersten, Marie José; Maucort-Boulch, Delphine; Ylstra, Bauke; Dijk, Erik van und Jong, Daphne de
(2023):
Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.
In: HemaSphere, Bd. 7, Nr. 4, e863
ORCID: https://orcid.org/0000-0002-0749-1389; Hiddemann, Wolfgang; Gaulard, Philippe; Salles, Gilles; Klapper, Wolfram; Xerri, Luc; Burton, Catherine; Tooze, Reuben M.; Smith, Alexandra G.; Buske, Christian; Scott, David W.; Natkunam, Yasodha; Advani, Ranjana; Sehn, Laurie H.; Raemaekers, John; Gribben, John; Lockmer, Sandra; Kimby, Eva; Kersten, Marie José; Maucort-Boulch, Delphine; Ylstra, Bauke; Dijk, Erik van und Jong, Daphne de
(2023):
Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.
In: HemaSphere, Bd. 7, Nr. 4, e863
2022
de Leval, Laurence; Alizadeh, Ash A.; Bergsagel, P. Leif; Campo, Elias; Davies, Andrew; Dogan, Ahmet; Fitzgibbon, Jude; Horwitz, Steven M.; Melnick, Ari M.; Morice, William G.; Morin, Ryan D.; Nadel, Bertrand; Pileri, Stefano A.; Rosenquist, Richard; Rossi, Davide; Salaverria, Itziar; Steidl, Christian; Treon, Steven P.; Zelenetz, Andrew D.; Advani, Ranjana H.; Allen, Carl E.; Ansell, Stephen M.; Chan, Wing C.; Cook, James R.; Cook, Lucy B.; D'Amore, Francesco; Dirnhofer, Stefan; Dreyling, Martin; Dunleavy, Kieron; Feldman, Andrew L.; Fend, Falko; Gaulard, Philippe; Ghia, Paolo; Gribben, John G.; Hermine, Olivier; Hodson, Daniel J.; Hsi, Eric D.; Inghirami, Giorgio; Jaffe, Elaine S.; Karube, Kennosuke; Kataoka, Keisuke; Klapper, Wolfram; Kim, Won Seog; King, Rebecca L.; Ko, Young H.; LaCasce, Ann S.; Lenz, Georg; Martin-Subero, Jose I.; Piris, Miguel A.; Pittaluga, Stefania; Pasqualucci, Laura; Quintanilla-Martinez, Leticia; Rodig, Scott J.; Rosenwald, Andreas; Salles, Gilles A.; San-Miguel, Jesus; Savage, Kerry J.; Sehn, Laurie H.; Semenzato, Gianpietro; Staudt, Louis M.; Swerdlow, Steven H.; Tam, Constantine S.; Trotman, Judith; Vose, Julie M.; Weigert, Oliver; Wilson, Wyndham H.; Winter, Jane N.; Wu, Catherine J.; Zinzani, Pier L.; Zucca, Emanuele; Bagg, Adam und Scott, David W.
(2022):
Genomic profiling for clinical decision making in lymphoid neoplasms.
In: Blood, Bd. 140, Nr. 21: S. 2193-2227
Villa, Diego; Hoster, Eva; Hermine, Olivier; Klapper, Wolfram; Szymczyk, Michal; Bosly, Andre; Unterhalt, Michael; Rimsza, Lisa M.; Ramsower, Colleen A.; Freeman, Ciara L.; Scott, David W.; Gerrie, Alina S.; Savage, Kerry J.; Sehn, Laurie H. und Dreyling, Martin
(2022):
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma.
In: Blood Advances, Bd. 6, Nr. 18: S. 5285-5294
Los-deVries, G. Tjitske; Stevens, Wendy B. C.; Dijk, Erik van; Langois-Jacques, Carole; Clear, Andrew J.; Stathi, Phylicia; Roemer, Margaretha G. M.; Mendeville, Matias; Hijmering, Nathalie J.; Sander, Birgitta; Rosenwald, Andreas; Calaminici, Maria; Hoster, Eva; Hiddemann, Wolfgang; Gaulard, Philippe; Salles, Gilles; Horn, Heike; Klapper, Wolfram; Xerri, Luc; Burton, Catherine; Tooze, Reuben M.; Smith, Alexandra G.; Buske, Christian; Scott, David W.; Natkunam, Yasodha; Advani, Ranjana; Sehn, Laurie H.; Raemaekers, John; Gribben, John; Kimby, Eva; Kersten, Marie Jose; Maucort-Boulch, Delphine; Ylstra, Bauke und Jong, Daphne de
(2022):
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.
In: Blood Advances, Bd. 6, Nr. 18: S. 5482-5493
2021
Strefford, Jonathan C.; Nowicka, Malgorzata; Hargreaves, Chantal E.; Burton, Cathy; Davies, Andrew; Ganderton, Rosalind; Hiddemann, Wolfgang; Iriyama, Chisako; Klapper, Wolfram; Latham, Kate V.; Martelli, Maurizio; Mir, Farheen; Parker, Helen; Potter, Kathleen N.; Rose-Zerilli, Matthew J. J.; Sehn, Laurie H.; Trneny, Marek; Vitolo, Umberto; Bolen, Christopher R.; Klein, Christian; Knapp, Andrea; Oestergaard, Mikkel Z. und Cragg, Mark S.
(2021):
Single-nucleotide Fc gamma receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma.
In: Blood Advances, Bd. 5, Nr. 15: S. 2935-2944
2020
Pott, Christiane; Sehn, Laurie H.; Belada, David; Gribben, John; Hoster, Eva; Kahl, Brad; Kehden, Britta; Nicolas-Virelizier, Emmanuelle; Spielewoy, Nathalie; Fingerle-Rowson, Guenter; Harbron, Chris; Mundt, Kirsten; Wassner-Fritsch, Elisabeth und Cheson, Bruce D.
(Februar 2020):
MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial.
In: Leukemia, Bd. 34, Nr. 2: S. 522-32
Rutherford, Sarah C.; Herold, Michael; Hiddemann, Wolfgang; Kostakoglu, Lale; Marcus, Robert; Martelli, Maurizio; Sehn, Laurie H.; Trneny, Marek; Trotman, Judith; Vitolo, Umberto; Nielsen, Tina; Mattiello, Federico; Sahin, Deniz; Sellam, Gila und Martin, Peter
(2020):
Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA.
In: Blood Advances, Bd. 4, Nr. 8: S. 1589-1593
2019
Silva, Anjali; Bassim, Sleiman; Sarkozy, Clémentine; Mottok, Anja; Lackraj, Tracy; Jurinovic, Vindi; Brodtkorb, Marianne; Lingjaerde, Ole Christian; Sehn, Laurie H.; Gascoyne, Randy D.; Weigert, Oliver; Steidl, Christian und Kridel, Robert
(2019):
Convergence of risk prediction models in follicular lymphoma.
In: Haematologica, Bd. 104, Nr. 6, e252-e255
Rosenwald, Andreas; Bens, Susanne; Advani, Ranjana; Barrans, Sharon; Copie-Bergman, Christiane; Elsensohn, Mad-Helenie; Natkunam, Yaso; Calaminici, Maria; Sander, Birgitta; Baia, Maryse; Smith, Alexandra; Painter, Daniel; Pham, Luu; Zhao, Shuchun; Ziepert, Marita; Jordanova, Ekaterina S.; Molina, Thierry J.; Kersten, Marie José; Kimby, Eva; Klapper, Wolfram; Raemaekers, John; Schmitz, Norbert; Jardin, Fabrice; Stevens, Wendy B. C.; Hoster, Eva; Hagenbeek, Anton; Gribben, John G.; Siebert, Reiner; Gascoyne, Randy D.; Scott, David W.; Gaulard, Philippe; Salles, Gilles; Burton, Catherine; Jong, Daphne de; Sehn, Laurie H. und Maucort-Boulch, Delphine
(2019):
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.
In: Journal of Clinical Oncology, Bd. 37, Nr. 35: S. 3359-3368
Morschhauser, Franck; Flinn, Ian W.; Advani, Ranjana; Sehn, Laurie H.; Diefenbach, Catherine; Kolibaba, Kathryn; Press, Oliver W.; Salles, Gilles; Tilly, Herve; Chen, Andy I.; Assouline, Sarit; Cheson, Bruce D.; Dreyling, Martin; Hagenbeek, Anton; Zinzani, Pier Luigi; Jones, Surai; Cheng, Ji; Lu, Dan; Penuel, Elicia; Hirata, Jamie; Wenger, Michael; Chu, Yu-Waye und Sharman, Jeff
(2019):
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS).
In: Lancet Haematology, Bd. 6, Nr. 5, E254-E265
Klanova, Magdalena; Oestergaard, Mikkel Z.; Trneny, Marek; Hiddemann, Wolfgang; Marcus, Robert; Sehn, Laurie H.; Vitolo, Umberto; Bazeos, Alexandra; Goede, Valentin; Zeuner, Harald; Knapp, Andrea; Sahin, Deniz; Spielewoy, Nathalie; Bolen, Christopher R.; Cardona, Andres; Klein, Christian; Venstrom, Jeffrey M.; Nielsen, Tina und Fingerle-Rowson, Guenter
(2019):
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy.
In: Clinical Cancer Research, Bd. 25, Nr. 15: S. 4634-4643
2018
Mottok, Anja; Jurinovic, Vindi; Farinha, Pedro; Rosenwald, Andreas; Leich, Ellen; Ott, German; Horn, Heike; Klapper, Wolfram; Boesl, Michael; Hiddemann, Wolfgang; Steidl, Christian; Connors, Joseph M.; Sehn, Laurie H.; Gascoyne, Randy D.; Hoster, Eva; Weigert, Oliver und Kridel, Robert
(Januar 2018):
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab-containing regimens.
In: Blood, Bd. 131, Nr. 2: S. 226-235
2017
Stevens, Wendy B. C.; Mendeville, Matias; Redd, Robert; Clear, Andrew J.; Bladergroen, Reno; Calaminici, Maria; Rosenwald, Andreas; Hoster, Eva; Hiddemann, Wolfgang; Gaulard, Philippe; Xerri, Luc; Salles, Gilles; Klapper, Wolfram; Pfreundschuh, Michael; Jack, Andrew; Gascoyne, Randy D.; Natkunam, Yasodha; Advani, Ranjana; Kimby, Eva; Sander, Birgitta; Sehn, Laurie H.; Hagenbeek, Anton; Raemaekers, John; Gribben, John; Kersten, Marie José; Ylstra, Bauke; Weller, Edie und Jong, Daphne de
(2017):
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.
In: Haematologica, Bd. 102, Nr. 8: S. 1413-1423